Irlab Therapeutics Ab Is A Biopharmaceutical Company Based In Swedendedicated To Developing New Treatments For Central Nervous Systemcnsdisorderswith A Strong Focus On Parkinsonae S Diseasefounded In 2013 And Headquartered In Gothenburgthe Company Employs 32 Staff And Is Listed On Nasdaq Stockholm Under The Ticker Irlab A Irlab Utilizes Its Proprietary Integrative Screening Processispplatformwhich Combines A Comprehensive Database Of Cns Compounds With Advanced Screening Methodsthis Innovative Approach Aids In The Efficient Discovery Of Drug Candidatesthe Company Is Advancing Two Clinical Stage Candidatesmesdopetamirl790 Aimed At Treating Levodopa Induced Dyskinesia And Parkinsonae S Disease Psychosisand Pirepematirl752 Which Targets Postural Dysfunction And Behavioral Symptoms In Dementiairlab S Mission Is To Improve Care For Patients With Cns Disorders Through Targeted Clinical Development And Innovative Pharmacology
No conferences found for this company.
| Company Name | Integrative Research Laboratories Ab |
| Country |
Sweden
|
| Address | N/A |
| Telephone | N/A |
| N/A |
